 | • レポートコード：GIR201102537 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、認識増強剤の世界市場を調査対象にし、認識増強剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経口、注射）、用途別分析（病院薬局、ドラッグストア、小売薬局）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Accelerated Intelligence、HVMN、Cognition Therapeutics、Cogstate、Biogen Idec ・メーカー別販売量、売上、市場シェア ・認識増強剤の地域別市場分析 ・認識増強剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・認識増強剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・認識増強剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・認識増強剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・認識増強剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・認識増強剤の種類別市場規模2015-2020：経口、注射 ・認識増強剤の用途別市場規模2015-2020：病院薬局、ドラッグストア、小売薬局 ・認識増強剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Cognition-Enhancing Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cognition-Enhancing Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cognition-Enhancing Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cognition-Enhancing Drugs market has been segmented into
Oral
Injection
By Application, Cognition-Enhancing Drugs has been segmented into:
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cognition-Enhancing Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Cognition-Enhancing Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cognition-Enhancing Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Cognition-Enhancing Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cognition-Enhancing Drugs Market Share Analysis
Cognition-Enhancing Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cognition-Enhancing Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cognition-Enhancing Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Cognition-Enhancing Drugs are:
Accelerated Intelligence
HVMN
Cognition Therapeutics
Cogstate
Biogen Idec
Among other players domestic and global, Cognition-Enhancing Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cognition-Enhancing Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cognition-Enhancing Drugs, with price, sales, revenue and global market share of Cognition-Enhancing Drugs in 2018 and 2019.
Chapter 3, the Cognition-Enhancing Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cognition-Enhancing Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cognition-Enhancing Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cognition-Enhancing Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cognition-Enhancing Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cognition-Enhancing Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Cognition-Enhancing Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.4 Overview of Global Cognition-Enhancing Drugs Market
1.4.1 Global Cognition-Enhancing Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Accelerated Intelligence
2.1.1 Accelerated Intelligence Details
2.1.2 Accelerated Intelligence Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Accelerated Intelligence SWOT Analysis
2.1.4 Accelerated Intelligence Product and Services
2.1.5 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 HVMN
2.2.1 HVMN Details
2.2.2 HVMN Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 HVMN SWOT Analysis
2.2.4 HVMN Product and Services
2.2.5 HVMN Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cognition Therapeutics
2.3.1 Cognition Therapeutics Details
2.3.2 Cognition Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cognition Therapeutics SWOT Analysis
2.3.4 Cognition Therapeutics Product and Services
2.3.5 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cogstate
2.4.1 Cogstate Details
2.4.2 Cogstate Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Cogstate SWOT Analysis
2.4.4 Cogstate Product and Services
2.4.5 Cogstate Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biogen Idec
2.5.1 Biogen Idec Details
2.5.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biogen Idec SWOT Analysis
2.5.4 Biogen Idec Product and Services
2.5.5 Biogen Idec Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cognition-Enhancing Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cognition-Enhancing Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cognition-Enhancing Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Cognition-Enhancing Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cognition-Enhancing Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Cognition-Enhancing Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cognition-Enhancing Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
4.5 South America Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cognition-Enhancing Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Cognition-Enhancing Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Cognition-Enhancing Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cognition-Enhancing Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Cognition-Enhancing Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cognition-Enhancing Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
6.3 UK Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
6.4 France Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cognition-Enhancing Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cognition-Enhancing Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cognition-Enhancing Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
7.5 India Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cognition-Enhancing Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Cognition-Enhancing Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Cognition-Enhancing Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cognition-Enhancing Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cognition-Enhancing Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cognition-Enhancing Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cognition-Enhancing Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Cognition-Enhancing Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Cognition-Enhancing Drugs Price by Type (2015-2020)
11 Global Cognition-Enhancing Drugs Market Segment by Application
11.1 Global Cognition-Enhancing Drugs Sales Market Share by Application (2015-2020)
11.2 Global Cognition-Enhancing Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Cognition-Enhancing Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cognition-Enhancing Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Cognition-Enhancing Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Cognition-Enhancing Drugs Market Forecast (2021-2025)
12.2.2 Europe Cognition-Enhancing Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cognition-Enhancing Drugs Market Forecast (2021-2025)
12.2.4 South America Cognition-Enhancing Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cognition-Enhancing Drugs Market Forecast (2021-2025)
12.3 Cognition-Enhancing Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Cognition-Enhancing Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Cognition-Enhancing Drugs Market Share Forecast by Type (2021-2025)
12.4 Cognition-Enhancing Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Cognition-Enhancing Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Cognition-Enhancing Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cognition-Enhancing Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cognition-Enhancing Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Accelerated Intelligence Basic Information, Manufacturing Base and Competitors
Table 8. Accelerated Intelligence Cognition-Enhancing Drugs Major Business
Table 9. Accelerated Intelligence Cognition-Enhancing Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Accelerated Intelligence SWOT Analysis
Table 11. Accelerated Intelligence Cognition-Enhancing Drugs Product and Services
Table 12. Accelerated Intelligence Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. HVMN Basic Information, Manufacturing Base and Competitors
Table 14. HVMN Cognition-Enhancing Drugs Major Business
Table 15. HVMN Cognition-Enhancing Drugs Total Revenue (USD Million) (2018-2019)
Table 16. HVMN SWOT Analysis
Table 17. HVMN Cognition-Enhancing Drugs Product and Services
Table 18. HVMN Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Cognition Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Cognition Therapeutics Cognition-Enhancing Drugs Major Business
Table 21. Cognition Therapeutics Cognition-Enhancing Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Cognition Therapeutics SWOT Analysis
Table 23. Cognition Therapeutics Cognition-Enhancing Drugs Product and Services
Table 24. Cognition Therapeutics Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Cogstate Basic Information, Manufacturing Base and Competitors
Table 26. Cogstate Cognition-Enhancing Drugs Major Business
Table 27. Cogstate Cognition-Enhancing Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Cogstate SWOT Analysis
Table 29. Cogstate Cognition-Enhancing Drugs Product and Services
Table 30. Cogstate Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 32. Biogen Idec Cognition-Enhancing Drugs Major Business
Table 33. Biogen Idec Cognition-Enhancing Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Biogen Idec SWOT Analysis
Table 35. Biogen Idec Cognition-Enhancing Drugs Product and Services
Table 36. Biogen Idec Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Cognition-Enhancing Drugs Sales by Manufacturer (2018-2019) (K MT)
Table 38. Global Cognition-Enhancing Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Cognition-Enhancing Drugs Sales by Regions (2015-2020) (K MT)
Table 40. Global Cognition-Enhancing Drugs Sales Market Share by Regions (2015-2020)
Table 41. Global Cognition-Enhancing Drugs Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Cognition-Enhancing Drugs Sales by Countries (2015-2020) (K MT)
Table 43. North America Cognition-Enhancing Drugs Sales Market Share by Countries (2015-2020)
Table 44. North America Cognition-Enhancing Drugs Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Cognition-Enhancing Drugs Revenue Market Share by Countries (2015-2020)
Table 46. Europe Cognition-Enhancing Drugs Sales by Countries (2015-2020) (K MT)
Table 47. Europe Cognition-Enhancing Drugs Sales Market Share by Countries (2015-2020)
Table 48. Europe Cognition-Enhancing Drugs Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Cognition-Enhancing Drugs Sales by Regions (2015-2020) (K MT)
Table 50. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Cognition-Enhancing Drugs Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Cognition-Enhancing Drugs Sales by Countries (2015-2020) (K MT)
Table 53. South America Cognition-Enhancing Drugs Sales Market Share by Countries (2015-2020)
Table 54. South America Cognition-Enhancing Drugs Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Cognition-Enhancing Drugs Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Cognition-Enhancing Drugs Sales by Countries (2015-2020) (K MT)
Table 57. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Cognition-Enhancing Drugs Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share by Countries (2015-2020)
Table 60. Global Cognition-Enhancing Drugs Sales by Type (2015-2020) (K MT)
Table 61. Global Cognition-Enhancing Drugs Sales Share by Type (2015-2020)
Table 62. Global Cognition-Enhancing Drugs Revenue by Type (2015-2020) (USD Million)
Table 63. Global Cognition-Enhancing Drugs Revenue Share by Type (2015-2020)
Table 64. Global Cognition-Enhancing Drugs Sales by Application (2015-2020) (K MT)
Table 65. Global Cognition-Enhancing Drugs Sales Share by Application (2015-2020)
Table 66. Global Cognition-Enhancing Drugs Sales Forecast by Regions (2021-2025) (K MT)
Table 67. Global Cognition-Enhancing Drugs Market Share Forecast by Regions (2021-2025)
Table 68. Global Cognition-Enhancing Drugs Sales Forecast by Type (2021-2025) (K MT)
Table 69. Global Cognition-Enhancing Drugs Market Share Forecast by Type (2021-2025)
Table 70. Global Cognition-Enhancing Drugs Sales Forecast by Application (2021-2025)
Table 71. Global Cognition-Enhancing Drugs Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cognition-Enhancing Drugs Picture
Figure 2. Global Sales Market Share of Cognition-Enhancing Drugs by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Cognition-Enhancing Drugs Sales Market Share by Application in 2018
Figure 6. Hospital Pharmacies Picture
Figure 7. Drug Stores Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Global Cognition-Enhancing Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Cognition-Enhancing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Cognition-Enhancing Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Cognition-Enhancing Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Cognition-Enhancing Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Cognition-Enhancing Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 35. Global Cognition-Enhancing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Cognition-Enhancing Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Cognition-Enhancing Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Cognition-Enhancing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Cognition-Enhancing Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Cognition-Enhancing Drugs Sales Market Share by Countries in 2018
Figure 46. North America Cognition-Enhancing Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Cognition-Enhancing Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Canada Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Mexico Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Europe Cognition-Enhancing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Cognition-Enhancing Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Cognition-Enhancing Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 55. UK Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 56. France Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Russia Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Italy Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Asia-Pacific Cognition-Enhancing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Cognition-Enhancing Drugs Revenue Market Share by Regions 2019
Figure 62. China Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Japan Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Korea Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 65. India Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Southeast Asia Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 67. South America Cognition-Enhancing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Cognition-Enhancing Drugs Sales Market Share by Countries in 2019
Figure 69. South America Cognition-Enhancing Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Middle East and Africa Cognition-Enhancing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Cognition-Enhancing Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Cognition-Enhancing Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Cognition-Enhancing Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Egypt Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Turkey Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 79. South Africa Cognition-Enhancing Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Global Cognition-Enhancing Drugs Sales and Growth Rate (2021-2025) (K MT)
Figure 81. Global Cognition-Enhancing Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Cognition-Enhancing Drugs Market Forecast (2021-2025) (K MT)
Figure 83. Europe Sales Cognition-Enhancing Drugs Market Forecast (2021-2025) (K MT)
Figure 84. Asia-Pacific Sales Cognition-Enhancing Drugs Market Forecast (2021-2025) (K MT)
Figure 85. South America Sales Cognition-Enhancing Drugs Market Forecast (2021-2025) (K MT)
Figure 86. Middle East & Africa Sales Cognition-Enhancing Drugs Market Forecast (2021-2025) (K MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
記憶増強薬の世界市場 2020年 Market Overview The global Memory Enhancing Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Memory Enhancing Drug m…- 眉毛強化セラムの世界市場 2020年 Market Overview The Eyebrow Enhancing Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- めまい薬の世界市場 2020年 Market Overview The global Vertigo Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vertigo Drugs market report pro…
- 処方用整形外科薬品の世界市場 2020年 Market Overview The global Prescription Orthopedic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescription Or…
- ポルフィリン症薬の世界市場 2020年 Market Overview The global Porphyrias Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Porphyrias Drugs market repo…